Terms: = Breast cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Treatment
65 results:
1. PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway.
Ma Y; Fang Z; Zhang H; Qi Y; Mao Y; Zheng J
Cell Death Dis; 2024 Apr; 15(3):199. PubMed ID: 38604999
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of neoadjuvant chemotherapy for breast cancer: a 20-year retrospective analysis of patients of a single institution.
Chen D; Wang Q; Dong M; Chen F; Huang A; Chen C; Lu Y; Zhao W; Wang L
BMC Cancer; 2023 Oct; 23(1):984. PubMed ID: 37845617
[TBL] [Abstract] [Full Text] [Related]
3. Cobalamin (Vitamin B12) in Anticancer Photodynamic Therapy with Zn(II) Phthalocyanines.
Mantareva V; Iliev I; Sulikovska I; Durmuş M; Angelov I
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901830
[TBL] [Abstract] [Full Text] [Related]
4. Cost-Effectiveness Analysis of Pertuzumab Plus Trastuzumab and Docetaxel Compared With Trastuzumab and Docetaxel in the Adjuvant treatment of Human Epidermal Growth Factor Receptor 2-Positive Metastatic breast cancer in Colombia.
Guevara-Cuellar CA; Parody-Rúa E; Rengifo-Mosquera MP; Del Mar Conde-Crespo M; Nuñez-Castro JM
Value Health Reg Issues; 2022 Nov; 32():109-118. PubMed ID: 36183606
[TBL] [Abstract] [Full Text] [Related]
5. Vitamin C-induced competitive binding of HIF-1α and p53 to ubiquitin E3 ligase cbl contributes to anti-breast cancer progression through p53 deacetylation.
Xiong Y; Xu S; Fu B; Tang W; Zaky MY; Tian R; Yao R; Zhang S; Zhao Q; Nian W; Lin X; Wu H
Food Chem Toxicol; 2022 Oct; 168():113321. PubMed ID: 35931247
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic breast cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study.
Ren W; Yu Y; Hong H; Wang Y; Gao Q; Chen Y; Chen P; Zhao J; Ou Q; Lin D; Fu T; Tan Y; Li C; Xie X; Ye G; Tang J; Yao H
Cancer Res Treat; 2022 Oct; 54(4):1038-1052. PubMed ID: 35130417
[TBL] [Abstract] [Full Text] [Related]
7. Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site.
Li X; Shao Y; Sheng L; Zhu J; Wang Z; Guo K; Sun L
Cancer Med; 2021 Feb; 10(3):974-988. PubMed ID: 33405390
[TBL] [Abstract] [Full Text] [Related]
8. Body weight management in overweight and obese breast cancer survivors.
Shaikh H; Bradhurst P; Ma LX; Tan SYC; Egger SJ; Vardy JL
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012110. PubMed ID: 33305350
[TBL] [Abstract] [Full Text] [Related]
9. Acute toxicity and tolerability of anthracycline-based chemotherapy regimens in older versus younger patients with breast cancer: real-world data.
Monteiro AR; Garcia AR; Póvoa S; Soares RF; Macedo F; Pereira TC; Domingues I; Pazos I; Sousa G
Support Care Cancer; 2021 May; 29(5):2347-2353. PubMed ID: 32918130
[TBL] [Abstract] [Full Text] [Related]
10. Manual lymphatic drainage treatment for lymphedema: a systematic review of the literature.
Thompson B; Gaitatzis K; Janse de Jonge X; Blackwell R; Koelmeyer LA
J Cancer Surviv; 2021 Apr; 15(2):244-258. PubMed ID: 32803533
[TBL] [Abstract] [Full Text] [Related]
11. Spontaneous Rib Fractures After breast cancer treatment Based on Bone Scans: Comparison Of Conventional Versus Hypofractionated Radiotherapy.
Kim DW; Kim JS; Kim K; Shin KH
Clin Breast Cancer; 2021 Feb; 21(1):e80-e87. PubMed ID: 32800490
[TBL] [Abstract] [Full Text] [Related]
12. Economic Evaluation of Cisplatin Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine for the treatment of First-Line Advanced Metastatic Triple-Negative breast cancer in China: Using Markov Model and Partitioned Survival Model.
Rui M; Shi F; Shang Y; Meng R; Li H
Adv Ther; 2020 Sep; 37(9):3761-3774. PubMed ID: 32647912
[TBL] [Abstract] [Full Text] [Related]
13. Healthcare providers' adherence to breast cancer guidelines in Europe: a systematic literature review.
Niño de Guzmán E; Song Y; Alonso-Coello P; Canelo-Aybar C; Neamtiu L; Parmelli E; Pérez-Bracchiglione J; Rabassa M; Rigau D; Parkinson ZS; Solà I; Vásquez-Mejía A; Ricci-Cabello I
Breast Cancer Res Treat; 2020 Jun; 181(3):499-518. PubMed ID: 32378052
[TBL] [Abstract] [Full Text] [Related]
14. β-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/cbl-b/EGFR pathway.
Deng M; Liu B; Song H; Yu R; Zou D; Chen Y; Ma Y; Lv F; Xu L; Zhang Z; Lv Q; Yang X; Che X; Qu X; Liu Y; Zhang Y; Hu X
Phytomedicine; 2020 Apr; 69():153184. PubMed ID: 32199253
[TBL] [Abstract] [Full Text] [Related]
15. PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer.
Wang X; Liu Y
Pathol Res Pract; 2020 Mar; 216(3):152802. PubMed ID: 32005408
[TBL] [Abstract] [Full Text] [Related]
16. Clonality, Antigen Recognition, and Suppression of CD8
Hammerl D; Massink MPG; Smid M; van Deurzen CHM; Meijers-Heijboer HEJ; Waisfisz Q; Debets R; Martens JWM
Clin Cancer Res; 2020 Jan; 26(2):505-517. PubMed ID: 31649042
[TBL] [Abstract] [Full Text] [Related]
17. Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experience.
Pérez Ramírez S; Del Monte-Millán M; López-Tarruella S; Martínez Jáñez N; Márquez-Rodas I; Lobo Samper F; Izarzugaza Perón Y; Rubio Terres C; Rubio Rodríguez D; García-Sáenz JÁ; Moreno Antón F; Zamora Auñón P; Arroyo Yustos M; Lara Álvarez MÁ; Ciruelos Gil EM; Manso Sánchez L; Echarri González MJ; Guerra Martínez JA; Jara Sánchez C; Bueno Muiño C; García Adrián S; Carrión Galindo JR; Valentín Maganto V; Martín M
Clin Transl Oncol; 2020 May; 22(5):717-724. PubMed ID: 31300934
[TBL] [Abstract] [Full Text] [Related]
18. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in breast cancer.
Jun W; Cong W; Xianxin X; Daqing J
Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
[TBL] [Abstract] [Full Text] [Related]
19. [cancers in systemic sclerosis : risk factors, impact on survival and literature review].
Catano J; Guedon A; Riviere S; Carrat F; Mahevas T; Fain O; Mekinian A
Rev Med Interne; 2019 Oct; 40(10):637-644. PubMed ID: 31255252
[TBL] [Abstract] [Full Text] [Related]
20. Therapeutic targeting of HER2-CB
Blasco-Benito S; Moreno E; Seijo-Vila M; Tundidor I; Andradas C; Caffarel MM; Caro-Villalobos M; Urigüen L; Diez-Alarcia R; Moreno-Bueno G; Hernández L; Manso L; Homar-Ruano P; McCormick PJ; Bibic L; Bernadó-Morales C; Arribas J; Canals M; Casadó V; Canela EI; Guzmán M; Pérez-Gómez E; Sánchez C
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3863-3872. PubMed ID: 30733293
[TBL] [Abstract] [Full Text] [Related]
[Next]
